Lund University, Food Technology, Engineering and Nutrition
Lund, 22100, Sweden
NCT Number: NCT05177172
In this project we will investigate synergistic effects of oat polar lipids and beta glucans on postprandial glucose tolerance
Looking for future studies?
Notify Me20 year–40 year
All sexes
Interventional
Not applicable
Lund, 22100, Sweden
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
higher dose betaglucans
lower dose beta glucans
low dose betaglucans in a combination with low dose of polar lipids
low dose polar lipids
No beta glucans or polar lipids
Time frame: 3 hours. Fasting (time =0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes
Postprandial glucose concentrations (mmol/L). The incremental area under the curve will be calculated and expressed as mmol*minutes/litre.
Time frame: 3 hours. Fasting (time =0 minutes), 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes, 180 minutes
Postprandial sensation of hunger, satiety, and desire to eat will be determined with a 100 millimeter visual analogue scale (VAS). The left end of the VAS scale represent "not at all" (e.g. hungry) and right end of the scale represented "extremely". One scale for each parameter will be used. The total area under the curve will be calculated, and the results will be expressed as millimeter*minutes.
Lund University
Other
Synergistic Effect of Oat Beta-glucans and Oat Polar Lipids on Postprandial Glucose Response
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05943886
Body Weight, Diabetes Mellitus
Changchun, Jilin, China
View Trial DetailsNCT05822544
Body Weight, Diabetes Mellitus
Auckland, New Zealand
View Trial DetailsNCT02218099
Chronic Disease, Chronic Kidney Disease (CKD)
Sofia, Bulgaria
View Trial DetailsNCT03802487
Diabetes Mellitus, Diabetes Mellitus, Type 2
Nottingham, United Kingdom
View Trial Details